Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-127199

Interim CEO & General Counsel gave up 191,303 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 200,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Vogt Frederick G · Interim CEO & General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-11 Exercise or conversion : show line 1 in the form +200,000 $7.55 $1,510,000 795,447 D
2026-11-11 Shares withheld for taxes : show line 2 in the form −191,303 $8.09 $1,547,641 604,144 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-11 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −200,000 0 D
Loading xslF345X06/tm2629737-1_4seq1.xml…